KALY and PURA - Kali-Extracts and Puration Announce First Ever 25 mg CBD Extract Formulation For Beverage Infusion
January 16 2019 - 1:44PM
InvestorsHub NewsWire
KALY and PURA - Kali-Extracts and
Puration Announce First Ever 25 mg CBD Extract Formulation For
Beverage Infusion
Dallas, TX -- January 16, 2019
-- InvestorsHub NewsWire -- Kali-Extracts, Inc. (Kali, Inc.
dba/Kali-Extracts, Inc.) (USOTC:
KALY) (“KALY”) and Puration, Inc, (USOTC:
PURA) (“PURA”) today announced a new 25 mg CBD Extract
formulation for beverage infusion. KALY owns and manages a
patented cannabis extraction process. PURA has licensed the
KALY patent for beverage infusion. PURA currently produces
EVERx CBD Sports Water infused with 10 mg of CBD. Together
KALY and PURA are designing a new private labeled CBD infused
beverage for Generex Biotechnology, Inc. (OTCBB:
GNBT). In response to feedback from PURA’s EVERx
distributors, KALY and PURA are now working together to refine a
new 25 mg CBD extract formulation.
“Through the retail outlets our
distributors serve, we are getting feedback that there is an
unserved demand for CBD infused beverages with 25 mg of CBD,” said
Brian Shible, CEO of PURA. “Not many beverages even have the
10 mg concentration we currently deliver. Next to no beverage
comes with 25 mg. We believe we can deliver 25 mg and still
maintain our clean refreshing taste. We are considering
introducing this first 25 mg beverage exclusively under the Generex
label.”
Puration
launched the EVERx CBD Sports Waters in the spring of 2017.
The company's sales grew 600% in the first year after the launch of
EVERx. Kiwi Strawberry and Lemon Lime flavors are now
available in addition the Original EVERx CBD Infused Sports
Water. EVERx has more than twice the CBD of most CBD
infused waters on the market. A proprietary technology
enables EVERx to suspend more CBD than its competitors and still
have a crystal-clear appearance and a refreshing
taste.
KALY recently acquired a biotech
company with a patented cannabis extraction process.
Accordingly, KALY updated its overall business plan (a presentation
on the company’s updated business plan is available on KALY’s website). Hemp4mula is part of
the updated business plan which management is rapidly
executing. The company recently announced a $300,000 hemp-derived CBD extraction
contract with Puration, Inc. (USOTC:
PURA). The CBD Kali-extracts will produce is to support
PURA’s contract to produce a private labeled CBD infused
Water for Generex.
Goldman Small Cap Research Report
published an analyst research report on KALY this past Tuesday,
January 8th, 2019 that highlights KALY’s cannabis
pharmaceutical value. The report is available under
“research” on the OTCMarkets website. The research
report is the first report from Goldman Small Cap Research as part
of an ongoing research engagement. The report outlines the
company’s current positioning and potential, upcoming milestones.
The report is intended to augment the current information available
on the OTCMarkets website. The report is also available to read or
download, along with associated disclosures and disclaimers,
at www.GoldmanResearch.com.
To learn more about the company
visit https://www.kali-extracts.com/
For more
information on Puration, visit http://www.purationinc.com
This press release contains
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"),
and as such, may involve risks and uncertainties. These forward
looking statements relate to, amongst other things, current
expectation of the business environment in which the company
operates, potential future performance, projections of future
performance and the perceived opportunities in the market. The
company's actual performance, results and achievements may differ
materially from the expressed or implied in such forward-looking
statements as a result of a wide range of
factors.
CONTACT:
Frederick Ferri
ir@kali-extracts.com
(214) 210-0459
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Sep 2024 to Oct 2024
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Oct 2023 to Oct 2024